# Ningbo Shuangcheng Pharmaceutical Co., Ltd – FDA Inspection, Nov 3, 2023

Source: https://www.keypedia.com/records/fda_inspections/ningbo-shuangcheng-pharmaceutical-co-ltd/dfd422c0-0d40-4f47-92a1-a0d7e2d57cda
Source feed: FDA_Inspections

> FDA inspection 1223659 of Ningbo Shuangcheng Pharmaceutical Co., Ltd, November 03, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223659
- Company Name: Ningbo Shuangcheng Pharmaceutical Co., Ltd
- Inspection Date: 2023-11-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 2

## Related Documents

- [FDA Inspection 1339592 - 2026-09-04](https://www.keypedia.com/records/fda_inspections/ningbo-shuangcheng-pharmaceutical-co-ltd/17e2411a-3756-499b-a594-12f541d7e50b)
- [FDA Inspection 1210070 - 2023-06-13](https://www.keypedia.com/records/fda_inspections/ningbo-shuangcheng-pharmaceutical-co-ltd/271040c2-bd93-4dd4-a634-5988ebc94816)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kevin-p-regan/b870e1f2-017c-44ab-bc99-1ca99b474a04)

Company: https://www.keypedia.com/companies/ningbo-shuangcheng-pharmaceutical-co-ltd/942c1651-ee36-4163-9687-ca694ddc24d2

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8